According to Madrigal Pharmaceuticals
's latest financial reports the company has $0.40 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.40 B | 105.35% |
2022-12-31 | $0.19 B | 0.65% |
2021-12-31 | $0.19 B | -18.28% |
2020-12-31 | $0.23 B | -42.39% |
2019-12-31 | $0.41 B | -12.67% |
2018-12-31 | $0.47 B | 161.71% |
2017-12-31 | $0.18 B | 400.57% |
2016-12-31 | $36.41 M | -174.44% |
2015-12-31 | $-48.92 M | -175.09% |
2014-12-31 | $65.13 M | 32.68% |
2013-12-31 | $49.09 M | -34.6% |
2012-12-31 | $75.06 M | 408.1% |
2011-12-31 | $14.77 M | -37.08% |
2010-12-31 | $23.47 M | -5.75% |
2009-12-31 | $24.91 M | -142.37% |
2008-12-31 | $-58.8 M | -336.15% |
2007-12-31 | $24.89 M | -1525.07% |
2006-12-31 | $-1.75 M | -103.33% |
2005-12-31 | $52.47 M | -55.51% |
2004-12-31 | $0.11 B | 53.41% |
2003-12-31 | $76.89 M | |
2001-12-31 | $2.74 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | 242.74% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $10.67 M | -97.37% | ๐บ๐ธ USA |